Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Pneumococcal vaccines in Nepal.

Russell FM, Mulholland K.

Lancet Infect Dis. 2019 Feb;19(2):115-116. doi: 10.1016/S1473-3099(18)30608-X. Epub 2019 Jan 8. No abstract available.

PMID:
30635254
2.

Streptococcus pneumoniae carriage prevalence in Nepal: evaluation of a method for delayed transport of samples from remote regions and implications for vaccine implementation.

Hanieh S, Hamaluba M, Kelly DF, Metz JA, Wyres KL, Fisher R, Pradhan R, Shakya D, Shrestha L, Shrestha A, Joshi A, Habens J, Maharjan BD, Thorson S, Bohler E, Yu LM, Kelly S, Plested E, John T, Werno AM, Adhikari N, Murdoch DR, Brueggemann AB, Pollard AJ.

PLoS One. 2014 Jun 6;9(6):e98739. doi: 10.1371/journal.pone.0098739. eCollection 2014.

3.

Use of weighted multivariate estimates in trials of multi-serotype vaccines to simplify interpretation of treatment differences.

Voysey M, Pollard AJ, Perera R, Shrestha S, Thorson S, Fanshawe TR.

PLoS One. 2018 Apr 27;13(4):e0196200. doi: 10.1371/journal.pone.0196200. eCollection 2018.

4.

Hospital-based surveillance of invasive pneumococcal disease among young children in urban Nepal.

Williams EJ, Thorson S, Maskey M, Mahat S, Hamaluba M, Dongol S, Werno AM, Yadav BK, Shah AS, Kelly DF, Adhikari N, Pollard AJ, Murdoch DR.

Clin Infect Dis. 2009 Mar 1;48 Suppl 2:S114-22. doi: 10.1086/596488.

PMID:
19191606
5.

Invasive pneumococcal disease in Kanti Children's Hospital, Nepal, as observed by the South Asian Pneumococcal Alliance network.

Shah AS, Knoll MD, Sharma PR, Moisi JC, Kulkarni P, Lalitha MK, Steinhoff M, Thomas K.

Clin Infect Dis. 2009 Mar 1;48 Suppl 2:S123-8. doi: 10.1086/596490.

PMID:
19191607
6.

Clinical profile of invasive pneumococcal diseases in Patan Hospital, Nepal.

Chhetri UD, Shrestha S, Pradhan R, Shrestha A, Adhikari N, Thorson S, Pollard AJ, Murdoch DR, Kelly DF.

Kathmandu Univ Med J (KUMJ). 2011 Jan-Mar;9(33):45-9.

PMID:
22610809
7.

Multi-serotype pneumococcal nasopharyngeal carriage prevalence in vaccine naïve Nepalese children, assessed using molecular serotyping.

Kandasamy R, Gurung M, Thapa A, Ndimah S, Adhikari N, Murdoch DR, Kelly DF, Waldron DE, Gould KA, Thorson S, Shrestha S, Hinds J, Pollard AJ.

PLoS One. 2015 Feb 2;10(2):e0114286. doi: 10.1371/journal.pone.0114286. eCollection 2015.

8.

Improving pneumococcal vaccination rates of medical inpatients in urban Nepal using quality improvement measures.

Bock A, Chintamaneni K, Rein L, Frazer T, Kayastha G, MacKinney T.

BMJ Qual Improv Rep. 2016 Nov 10;5(1). pii: u212047.w4835. eCollection 2016.

9.

Comparison of two-dose priming plus 9-month booster with a standard three-dose priming schedule for a ten-valent pneumococcal conjugate vaccine in Nepalese infants: a randomised, controlled, open-label, non-inferiority trial.

Hamaluba M, Kandasamy R, Upreti SR, Subedi GR, Shrestha S, Bhattarai S, Gurung M, Pradhan R, Voysey M, Gurung S, Pradhan S, Thapa AK, Maharjan R, Kiran U, Kerridge SA, Hinds J, van der Klis F, Snape MD, Murdoch DR, Kelly S, Kelly DF, Adhikari N, Thorson S, Pollard AJ.

Lancet Infect Dis. 2015 Apr;15(4):405-14. doi: 10.1016/S1473-3099(15)70007-1. Epub 2015 Feb 18.

PMID:
25701560
10.

Development and evaluation of pneumococcal conjugate vaccines: clinical trials and control tests.

Lee LH, Lee CJ, Frasch CE.

Crit Rev Microbiol. 2002;28(1):27-41. Review.

PMID:
12003039
11.

Efficacy and effectiveness of extended-valency pneumococcal conjugate vaccines.

Lee H, Choi EH, Lee HJ.

Korean J Pediatr. 2014 Feb;57(2):55-66. doi: 10.3345/kjp.2014.57.2.55. Epub 2014 Feb 24.

12.

The potential indirect effect of conjugate pneumococcal vaccines.

O'Brien KL, Dagan R.

Vaccine. 2003 May 16;21(17-18):1815-25. Review.

PMID:
12706665
13.

Safety and tolerability of pneumococcal vaccines in children.

Esposito S, Principi N.

Expert Opin Drug Saf. 2016 Jun;15(6):777-85. doi: 10.1517/14740338.2016.1160056. Epub 2016 Mar 21. Review.

PMID:
26923347
14.

Review: current and new generation pneumococcal vaccines.

Feldman C, Anderson R.

J Infect. 2014 Oct;69(4):309-25. doi: 10.1016/j.jinf.2014.06.006. Epub 2014 Jun 23. Review.

PMID:
24968238
15.

Pneumococcal vaccines for children: a global public health priority.

Pittet LF, Posfay-Barbe KM.

Clin Microbiol Infect. 2012 Oct;18 Suppl 5:25-36. doi: 10.1111/j.1469-0691.2012.03938.x. Epub 2012 Aug 6. Review.

16.

Pneumococcal whole-cell and protein-based vaccines: changing the paradigm.

Pichichero ME.

Expert Rev Vaccines. 2017 Dec;16(12):1181-1190. doi: 10.1080/14760584.2017.1393335. Review.

17.

Potential impact of conjugate pneumococcal vaccines on pediatric pneumococcal diseases.

O'Brien KL, Santosham M.

Am J Epidemiol. 2004 Apr 1;159(7):634-44. Review.

PMID:
15033641
18.

Status of research and development of pediatric vaccines for Streptococcus pneumoniae.

Alderson MR.

Vaccine. 2016 Jun 3;34(26):2959-2961. doi: 10.1016/j.vaccine.2016.03.107. Epub 2016 Apr 12.

19.

Development of pneumococcal vaccines over the last 10 years.

Principi N, Esposito S.

Expert Opin Biol Ther. 2018 Jan;18(1):7-17. doi: 10.1080/14712598.2018.1384462. Epub 2017 Oct 12. Review.

PMID:
29022363
20.

Pneumococcal vaccines: history, current status, and future directions.

Butler JC, Shapiro ED, Carlone GM.

Am J Med. 1999 Jul 26;107(1A):69S-76S. Review.

PMID:
10451012

Supplemental Content

Support Center